• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Overexpression of the Ctla-4 isoform lacking exons 2 and 3 causes autoimmunity.CTLA-4 异构体的过表达导致自身免疫。
J Immunol. 2012 Jan 1;188(1):155-62. doi: 10.4049/jimmunol.1102042. Epub 2011 Nov 28.
2
Novel pathogenic variants in CTLA4 and LRBA immune dysregulation: Reduced CTLA-4 expression with normal expression of co-stimulatory surface molecules.CTLA4和LRBA免疫失调中的新型致病变异:共刺激表面分子表达正常但CTLA-4表达降低。
Clin Immunol. 2025 Jul 10;280:110565. doi: 10.1016/j.clim.2025.110565.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma.肢端雀斑样痣黑色素瘤国际患者队列中程序性细胞死亡蛋白1与细胞毒性T淋巴细胞相关蛋白4联合阻断治疗
Br J Dermatol. 2025 Jan 24;192(2):316-326. doi: 10.1093/bjd/ljae401.
6
The B7-independent isoform of CTLA-4 functions to regulate autoimmune diabetes.CTLA-4 的 B7 非依赖性同种型可调节自身免疫性糖尿病。
J Immunol. 2013 Feb 1;190(3):961-9. doi: 10.4049/jimmunol.1201362. Epub 2013 Jan 4.
7
Full-Length Transcriptome Sequencing Reveals Treg-Specific Isoform Expression upon Activation.全长转录组测序揭示激活后调节性T细胞特异性异构体表达
Int J Mol Sci. 2025 Jun 30;26(13):6302. doi: 10.3390/ijms26136302.
8
Response to self antigen imprints regulatory memory in tissues.对自身抗原印记在组织中调节记忆。
Nature. 2011 Nov 27;480(7378):538-42. doi: 10.1038/nature10664.
9
Type 1 Diabetes: A Guide to Autoimmune Mechanisms for Clinicians.1型糖尿病:临床医生自身免疫机制指南
Diabetes Obes Metab. 2025 May 15. doi: 10.1111/dom.16460.
10
Identification of novel, clinically correlated autoantigens in the monogenic autoimmune syndrome APS1 by proteome-wide PhIP-Seq.通过全蛋白质组 PhIP-Seq 鉴定单基因自身免疫综合征 APS1 中的新型临床相关自身抗原。
Elife. 2020 May 15;9:e55053. doi: 10.7554/eLife.55053.

引用本文的文献

1
A splicing isoform of PD-1 promotes tumor progression as a potential immune checkpoint.PD-1 的剪接异构体作为潜在的免疫检查点促进肿瘤进展。
Nat Commun. 2024 Oct 23;15(1):9114. doi: 10.1038/s41467-024-53561-2.
2
Identification of Alternative Splicing Events Associated with Paratuberculosis in Dairy Cattle Using Multi-Tissue RNA Sequencing Data.利用多组织 RNA 测序数据鉴定与奶牛副结核病相关的可变剪接事件。
Genes (Basel). 2022 Mar 11;13(3):497. doi: 10.3390/genes13030497.
3
Immune Checkpoint Inhibitors and Neurotoxicity.免疫检查点抑制剂和神经毒性。
Curr Neuropharmacol. 2021;19(8):1246-1263. doi: 10.2174/1570159X19666201230151224.
4
RNA Splicing and Disease: Animal Models to Therapies.RNA 剪接与疾病:从动物模型到治疗策略。
Trends Genet. 2019 Jan;35(1):68-87. doi: 10.1016/j.tig.2018.10.002. Epub 2018 Nov 19.
5
Neurological complications of immune checkpoint inhibitors: what happens when you 'take the brakes off' the immune system.免疫检查点抑制剂的神经系统并发症:当你“松开免疫系统的刹车”时会发生什么。
Ther Adv Neurol Disord. 2018 Sep 14;11:1756286418799864. doi: 10.1177/1756286418799864. eCollection 2018.
6
Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.B7-CD28配体-受体家族中的共抑制通路。
Immunity. 2016 May 17;44(5):955-72. doi: 10.1016/j.immuni.2016.05.002.
7
dNP2 is a blood-brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis.dNP2是一种可穿透血脑屏障的肽,能够递送细胞毒性T淋巴细胞相关抗原4(ctCTLA-4)蛋白以改善实验性自身免疫性脑脊髓炎。
Nat Commun. 2015 Sep 15;6:8244. doi: 10.1038/ncomms9244.
8
Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity.成年期调节性T细胞上CTLA-4的缺失导致对自身免疫的抗性。
J Exp Med. 2015 Sep 21;212(10):1603-21. doi: 10.1084/jem.20141030. Epub 2015 Sep 14.
9
64Cu-DOTA-anti-CTLA-4 mAb enabled PET visualization of CTLA-4 on the T-cell infiltrating tumor tissues.64Cu-DOTA-抗CTLA-4单克隆抗体能够通过正电子发射断层显像(PET)显示T细胞浸润的肿瘤组织上的CTLA-4。
PLoS One. 2014 Nov 3;9(11):e109866. doi: 10.1371/journal.pone.0109866. eCollection 2014.
10
Opposing effects of CTLA4 insufficiency on regulatory versus conventional T cells in autoimmunity converge on effector memory in target tissue.在自身免疫中,CTLA4功能不全对调节性T细胞与常规T细胞的相反作用均集中于靶组织中的效应记忆T细胞。
J Immunol. 2014 Nov 1;193(9):4368-80. doi: 10.4049/jimmunol.1400876. Epub 2014 Sep 22.

本文引用的文献

1
The soluble CTLA-4 splice variant protects from type 1 diabetes and potentiates regulatory T-cell function.可溶性 CTLA-4 剪接变异体可预防 1 型糖尿病并增强调节性 T 细胞的功能。
Diabetes. 2011 Jul;60(7):1955-63. doi: 10.2337/db11-0130. Epub 2011 May 20.
2
Genetic evidence that the differential expression of the ligand-independent isoform of CTLA-4 is the molecular basis of the Idd5.1 type 1 diabetes region in nonobese diabetic mice.基因证据表明,CTLA-4配体非依赖性异构体的差异表达是非肥胖糖尿病小鼠Idd5.1型糖尿病区域的分子基础。
J Immunol. 2009 Oct 15;183(8):5146-57. doi: 10.4049/jimmunol.0802610. Epub 2009 Sep 25.
3
CTLA-4 control over Foxp3+ regulatory T cell function.细胞毒性T淋巴细胞相关抗原4对叉头框蛋白3阳性调节性T细胞功能的调控
Science. 2008 Oct 10;322(5899):271-5. doi: 10.1126/science.1160062.
4
Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo.阻断CD4+CD25+调节性T细胞上的CTLA-4可在体内消除其功能。
J Immunol. 2006 Oct 1;177(7):4376-83. doi: 10.4049/jimmunol.177.7.4376.
5
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.致病性效应T辅助细胞17(TH17)和调节性T细胞产生的相互发育途径。
Nature. 2006 May 11;441(7090):235-8. doi: 10.1038/nature04753. Epub 2006 Apr 30.
6
A molecular perspective of CTLA-4 function.CTLA-4功能的分子视角。
Annu Rev Immunol. 2006;24:65-97. doi: 10.1146/annurev.immunol.24.021605.090535.
7
B7-independent inhibition of T cells by CTLA-4.CTLA-4对T细胞的B7非依赖性抑制作用。
J Immunol. 2005 Jul 1;175(1):177-81. doi: 10.4049/jimmunol.175.1.177.
8
Functional immunomics: microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induced diabetes.功能免疫组学:IgG自身抗体库的微阵列分析可预测小鼠对诱导性糖尿病的未来反应。
Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2(Suppl 2):14615-21. doi: 10.1073/pnas.0404848101. Epub 2004 Aug 12.
9
An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells.一种缺乏B7结合域的自身免疫性疾病相关CTLA-4剪接变体在T细胞中产生负向信号。
Immunity. 2004 May;20(5):563-75. doi: 10.1016/s1074-7613(04)00110-4.
10
Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis.髓鞘少突胶质细胞糖蛋白特异性T细胞受体转基因小鼠会发生自发性自身免疫性视神经炎。
J Exp Med. 2003 May 5;197(9):1073-81. doi: 10.1084/jem.20021603.

CTLA-4 异构体的过表达导致自身免疫。

Overexpression of the Ctla-4 isoform lacking exons 2 and 3 causes autoimmunity.

机构信息

Center for Neurologic Diseases, Harvard Medical School, Boston, MA 02115, USA.

出版信息

J Immunol. 2012 Jan 1;188(1):155-62. doi: 10.4049/jimmunol.1102042. Epub 2011 Nov 28.

DOI:10.4049/jimmunol.1102042
PMID:22124121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3245861/
Abstract

CTLA-4 is a potent inhibitor of T cell activation, primarily upon binding to its costimulatory ligands (B7.1 and B7.2) expressed on APCs. However, variants of CTLA-4 can also function independently of B7 molecules. 1/4CTLA-4 is a highly conserved isoform encoded by exons 1 and 4 of the Ctla4 gene that lacks the ligand-binding and the transmembrane domains, and as yet, its function is not known. To investigate the function of 1/4CTLA-4, we generated transgenic (Tg) mice overexpressing this variant. Cytokine production by 1/4CTLA-4 Tg T cells was elevated compared with wild type T cells. The frequency of CD44(high) memory T cells in 1/4CTLA-4 Tg mice was increased, and as the mice aged, the frequency further increased. 1/4CTLA-4 Tg mice >1 y old had increased expression of T cell activation markers and developed spontaneous autoimmunity, including elevated production of autoantibodies. In contrast with young 1/4CTLA-4 Tg mice, aged 1/4CTLA-4 Tg mice had elevated frequencies of Foxp3(+) regulatory T cells, but the regulatory T cells from these mice were not able to inhibit colitis development. Collectively, these data suggest that the function of the 1/4CTLA-4 isoform is distinct from that of CTLA-4 in that it enhances T cell activation and promotes autoimmunity rather than inhibiting immune responses.

摘要

CTLA-4 是 T 细胞激活的有效抑制剂,主要通过与其在 APC 上表达的共刺激配体(B7.1 和 B7.2)结合来发挥作用。然而,CTLA-4 的变体也可以独立于 B7 分子发挥作用。1/4CTLA-4 是由 Ctla4 基因的外显子 1 和 4 编码的高度保守同工型,缺乏配体结合和跨膜结构域,其功能尚不清楚。为了研究 1/4CTLA-4 的功能,我们生成了过表达这种变体的转基因 (Tg) 小鼠。与野生型 T 细胞相比,1/4CTLA-4 Tg T 细胞的细胞因子产生增加。1/4CTLA-4 Tg 小鼠中 CD44(high)记忆 T 细胞的频率增加,随着小鼠年龄的增长,频率进一步增加。1/4CTLA-4 Tg 小鼠>1 岁时,T 细胞激活标志物的表达增加,并发生自发性自身免疫,包括自身抗体产生增加。与年轻的 1/4CTLA-4 Tg 小鼠不同,年老的 1/4CTLA-4 Tg 小鼠中 Foxp3(+)调节性 T 细胞的频率升高,但这些小鼠的调节性 T 细胞不能抑制结肠炎的发展。综上所述,这些数据表明,1/4CTLA-4 同工型的功能与 CTLA-4 不同,它增强了 T 细胞的激活,并促进了自身免疫,而不是抑制免疫反应。